Literature DB >> 28247041

Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.

Yu-Ichi Yamada1,2, Gen Yamada3, Mitsuo Otsuka1, Hirotaka Nishikiori1, Kimiyuki Ikeda1, Yasuaki Umeda1, Hirofumi Ohnishi4, Koji Kuronuma1, Hirofumi Chiba1, Jörg Ingo Baumbach5, Hiroki Takahashi1.   

Abstract

Purpose Human breath analysis is proposed with increasing frequency as a useful tool in clinical application. We performed this study to find the characteristic volatile organic compounds (VOCs) in the exhaled breath of patients with idiopathic pulmonary fibrosis (IPF) for discrimination from healthy subjects. Methods VOCs in the exhaled breath of 40 IPF patients and 55 healthy controls were measured using a multi-capillary column and ion mobility spectrometer. The patients were examined by pulmonary function tests, blood gas analysis, and serum biomarkers of interstitial pneumonia. Results We detected 85 VOC peaks in the exhaled breath of IPF patients and controls. IPF patients showed 5 significant VOC peaks; p-cymene, acetoin, isoprene, ethylbenzene, and an unknown compound. The VOC peak of p-cymene was significantly lower (p < 0.001), while the VOC peaks of acetoin, isoprene, ethylbenzene, and the unknown compound were significantly higher (p < 0.001 for all) compared with the peaks of controls. Comparing VOC peaks with clinical parameters, negative correlations with VC (r =-0.393, p = 0.013), %VC (r =-0.569, p < 0.001), FVC (r = -0.440, p = 0.004), %FVC (r =-0.539, p < 0.001), DLco (r =-0.394, p = 0.018), and %DLco (r =-0.413, p = 0.008) and a positive correlation with KL-6 (r = 0.432, p = 0.005) were found for p-cymene. Conclusion We found characteristic 5 VOCs in the exhaled breath of IPF patients. Among them, the VOC peaks of p-cymene were related to the clinical parameters of IPF. These VOCs may be useful biomarkers of IPF.

Entities:  

Keywords:  Exhaled breath; Idiopathic pulmonary fibrosis; Ion mobility spectrometer; Multi-capillary column; Volatile organic compound

Mesh:

Substances:

Year:  2017        PMID: 28247041     DOI: 10.1007/s00408-017-9979-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  33 in total

1.  Point-of-care breath test for biomarkers of active pulmonary tuberculosis.

Authors:  Michael Phillips; Victoria Basa-Dalay; Jaime Blais; Graham Bothamley; Anirudh Chaturvedi; Kinjal D Modi; Mauli Pandya; Maria Piedad R Natividad; Urvish Patel; Nagsen N Ramraje; Peter Schmitt; Zarir F Udwadia
Journal:  Tuberculosis (Edinb)       Date:  2012-05-29       Impact factor: 3.131

2.  Detection of lung cancer by sensor array analyses of exhaled breath.

Authors:  Roberto F Machado; Daniel Laskowski; Olivia Deffenderfer; Timothy Burch; Shuo Zheng; Peter J Mazzone; Tarek Mekhail; Constance Jennings; James K Stoller; Jacqueline Pyle; Jennifer Duncan; Raed A Dweik; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

3.  Ion mobility spectrometry in the diagnosis of sarcoidosis: results of a feasibility study.

Authors:  M Westhoff; P Litterst; L Freitag; J I Baumbach
Journal:  J Physiol Pharmacol       Date:  2007-11       Impact factor: 3.011

4.  Breath isoprene during acute respiratory exacerbation in cystic fibrosis.

Authors:  L T McGrath; R Patrick; P Mallon; L Dowey; B Silke; W Norwood; S Elborn
Journal:  Eur Respir J       Date:  2000-12       Impact factor: 16.671

5.  Breath sulfides and pulmonary function in cystic fibrosis.

Authors:  M A Kamboures; D R Blake; D M Cooper; R L Newcomb; M Barker; J K Larson; S Meinardi; E Nussbaum; F S Rowland
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

Review 6.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 7.  Review on ion mobility spectrometry. Part 1: current instrumentation.

Authors:  R Cumeras; E Figueras; C E Davis; J I Baumbach; I Gràcia
Journal:  Analyst       Date:  2015-03-07       Impact factor: 4.616

Review 8.  IPF: new insight on pathogenesis and treatment.

Authors:  S Harari; A Caminati
Journal:  Allergy       Date:  2010-02-01       Impact factor: 13.146

9.  Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.

Authors:  M Westhoff; P Litterst; L Freitag; W Urfer; S Bader; J-I Baumbach
Journal:  Thorax       Date:  2009-01-21       Impact factor: 9.139

10.  Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.

Authors:  Vasiliki Besa; Helmut Teschler; Isabella Kurth; Amir Maqbul Khan; Paul Zarogoulidis; Joerg Ingo Baumbach; Urte Sommerwerck; Lutz Freitag; Kaid Darwiche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-23
View more
  5 in total

Review 1.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

2.  Volatile organic compounds in ventilated critical care patients: a systematic evaluation of cofactors.

Authors:  Tobias Hüppe; Dominik Lorenz; Mario Wachowiak; Felix Maurer; Andreas Meiser; Heinrich Groesdonk; Tobias Fink; Daniel I Sessler; Sascha Kreuer
Journal:  BMC Pulm Med       Date:  2017-08-22       Impact factor: 3.317

3.  Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling.

Authors:  Michael Jonathan Hewitt; Ilaria Belluomo; Simone Zuffa; Piers R Boshier; Antonis Myridakis
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

4.  Exhaled Volatile Organic Compounds during Inflammation Induced by TNF-α in Ventilated Rats.

Authors:  Frederic W Albrecht; Felix Maurer; Lukas M Müller-Wirtz; Michaela H Schwaiblmair; Tobias Hüppe; Beate Wolf; Daniel I Sessler; Thomas Volk; Sascha Kreuer; Tobias Fink
Journal:  Metabolites       Date:  2020-06-15

5.  The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.

Authors:  L Plantier; A Smolinska; R Fijten; M Flamant; J Dallinga; J J Mercadier; D Pachen; M P d'Ortho; F J van Schooten; B Crestani; A W Boots
Journal:  Respir Res       Date:  2022-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.